Advances in single-cell technology have led to the discovery of multiple TAM subpopulations, such as thrombospondin-1+ (THBS-1+) macrophages in hepatocellular carcinoma and FN1+ TAMs in gliomas, each with unique transcriptional profiles and clinical significance. This evidence concerns the gene FN1 and central nervous system cancer.